1. Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells
    Sk Ramiz Islam et al, 2024, Metabolomics CrossRef

  2. Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells


    Lina Mi et al, 2020, Cancer Management and Research CrossRef
  3. Effects of Metformin Combined With Antifolates on HepG2 Cell Metabolism and Cellular Proliferation
    Sherouk M. Tawfik et al, 2022, Frontiers in Oncology CrossRef
  4. Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients
    Woo Jin Jung et al, 2022, Scientific Reports CrossRef
  5. Metformin suppresses Nrf2-mediated chemoresistance in hepatocellular carcinoma cells by increasing glycolysis
    Liangyu Cai et al, 2020, Aging CrossRef
  6. Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells
    Amjad Ali et al, 2022, Endocrine CrossRef
  7. Metformin-induced AMPK activation promotes cisplatin resistance through PINK1/Parkin dependent mitophagy in gastric cancer
    Yi-Yi Xiao et al, 2022, Frontiers in Oncology CrossRef
  8. GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications
    Yi-Ning Du et al, 2024, Journal of Hepatocellular Carcinoma CrossRef